Intended for healthcare professionals

CCBYNC Open access

Rapid response to:

Research

Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study

BMJ 2020; 371 doi: https://doi.org/10.1136/bmj.m4266 (Published 08 December 2020) Cite this as: BMJ 2020;371:m4266

Rapid Response:

Re: Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study

Dear Editor,

I am puzzled that no conflicts of interest have been declared in this paper, when one author, Børge G. Nordestgaard, has declared several relevant conflicts of interest in another paper published this year (1). These are shown as "B.G.N. reports consultancies and honoraria for lectures from AstraZeneca, Sanofi, Regeneron, Amgen, Akcea, Kowa, Novartis, Novo Nordisk”.

(1) Boren J et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal (2020) 41, 2313–2330

Competing interests: Members of the international Network of Cholesterol Skeptics

21 December 2020
Andrew N Bamji
Retired consultant rheumatologist
None
Rye